FDA Approval: Ibrutinib for Patients with Previously Treated Mantle Cell Lymphoma and Previously Treated Chronic Lymphocytic LeukemiaR. Angelo de Claro, Richard Pazdur, Karen M. McGinn et al.|Clinical Cancer Research|2015Cited by 165
Reimagining patient-centric cancer clinical trials: a multi-stakeholder international coalitionBob T. Li, Yi‐Long Wu, Elizabeth Franklin et al.|Nature Medicine|2022Cited by 52
Second cancers in adults with acute promyelocytic leukemia treated with or without arsenic trioxide: a SEER-medicare analysisKelly J. Norsworthy, David J. Graham, Armen Avagyan et al.|Leukemia|2020Cited by 32
Dose Finding in Late-Phase Drug DevelopmentLei Nie, Rajeshwari Sridhara, Kyung Y. Lee et al.|Therapeutic Innovation & Regulatory Science|2017Cited by 2